Institutional Ownership Blueprint Medicines Corp (BPMC)
This table provides information about the institutional ownership of Blueprint Medicines Corp (BPMC). We have compiled data on the 386 institutions that hold shares in the stock, with a total of 68.6 Million shares, which have been reported (via 13F filing form) to have a value of $8.88 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bokf, Na
Tulsa, OK |
Aug 12, 2025 Q2 2025 |
8
shares
|
$1,035
0.0% of portfolio
|
Q4 2024
New holding
|
|
Cassady Schiller Wealth Management, LLC
Cincinnati, OH |
Feb 10, 2025 Q4 2024 |
8
shares
|
$1,035
0.0% of portfolio
|
Q4 2024
New holding
|
|
Exane Derivatives
|
Jul 12, 2022 Q2 2022 |
8
shares
|
$1,035
0.0% of portfolio
|
Q2 2022
Reduced 98.59%
|
|
Geneos Wealth Management Inc.
|
May 21, 2025 Q1 2025 |
8
shares
|
$1,035
0.0% of portfolio
|
Q1 2025
New holding
|
|
Skopos Labs, Inc.
Riverhead, NY |
Aug 12, 2025 Q2 2025 |
7
shares
|
$906
0.0% of portfolio
|
Q1 2025
New holding
|
|
Mai Capital Management
|
May 15, 2025 Q1 2025 |
6
shares
|
$776
0.0% of portfolio
|
Q1 2025
New holding
|
|
Sbi Securities Co., Ltd.
Tokyo, M0 |
Aug 07, 2025 Q2 2025 |
5
shares
|
$647
0.0% of portfolio
|
Q2 2025
Reduced 50.0%
|
|
New Edge Advisors, LLC
New Orleans, LA |
May 15, 2025 Q1 2025 |
4
shares
|
$517
0.0% of portfolio
|
Q4 2022
New holding
|
|
Larson Financial Group LLC
|
Aug 08, 2025 Q2 2025 |
3
shares
|
$388
0.0% of portfolio
|
Q2 2025
Added 50.0%
|
|
Capital Advisors, Ltd. LLC
|
Jul 24, 2025 Q2 2025 |
3
shares
|
$388
0.0% of portfolio
|
Q4 2023
New holding
|
|
Concord Wealth Partners
|
Jul 25, 2025 Q2 2025 |
1
shares
|
$129
0.0% of portfolio
|
Q2 2025
New holding
|
|
Transamerica Financial Advisors, Inc.
Clearwater, FL |
May 14, 2025 Q1 2025 |
1
shares
|
$129
0.0% of portfolio
|
Q1 2023
Reduced 97.56%
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Aug 12, 2025 Q2 2025 |
0
shares
|
$0
100.0% of portfolio
|
Q2 2025
New holding
|